Cardinal Health agrees to extend CVS deal through 2032: what it means for Cardinal Health stock
Published on 10/17/2026 at 10:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAgreement timeline and next session
- Cardinal Health announced the CVS Health letter of intent on October 1, 2026.
- The proposed distribution agreement would run through June 30, 2032.
- The next Xetra session is scheduled for October 19, 2026.
Cardinal Health announced on October 1, 2026, that it had entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032, according to PR Newswire.
Market context: Market report S&P 500.
CVS distribution agreement
The letter of intent covers Cardinal Health's existing scope of distribution services. In connection with the renewal, Cardinal Health reaffirmed fiscal year 2027 non-GAAP earnings-per-share growth guidance of 13 percent to 15 percent, equivalent to USD 12.40 to USD 12.60, and long-term non-GAAP earnings-per-share growth guidance of 12 percent to 14 percent. The guidance was based on adjusted fiscal year 2026 results excluding the fiscal year 2026 benefit from an IEEPA tariff refund. These details were reported in the company release.
The next price is shown from the start of trading by the continuously updated real-time quote of Cardinal Health stock.
Next company date
Cardinal Health plans to release first-quarter results for fiscal year 2027 on November 5, 2026, before trading begins on the New York Stock Exchange. The company said its webcast discussion will begin at 8:30 a.m. Eastern. The announcement was published in the Cardinal Health Newsroom.
Next Xetra session
The next Xetra session is scheduled for October 19, 2026.
